MetLife Investment Management’s CNO Financial Group CNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5M | Buy |
98,046
+1,847
| +2% | +$85.8K | 0.02% | 636 |
|
|
2026
Q1 | $3.95M | Sell |
96,199
-1,886
| -2% | -$78.8K | 0.02% | 733 |
|
|
2025
Q4 | $4.17M | Sell |
98,085
-6,150
| -6% | -$251K | 0.02% | 705 |
|
|
2025
Q3 | $4.12M | Sell |
104,235
-6,720
| -6% | -$257K | 0.02% | 729 |
|
|
2025
Q2 | $4.28M | Sell |
110,955
-2,950
| -3% | -$112K | 0.03% | 644 |
|
|
2025
Q1 | $4.74M | Sell |
113,905
-6,069
| -5% | -$242K | 0.03% | 638 |
|
|
2024
Q4 | $4.46M | Buy |
119,974
+7,635
| +7% | +$284K | 0.02% | 625 |
|
|
2024
Q3 | $3.94M | Sell |
112,339
-5,102
| -4% | -$164K | 0.02% | 667 |
|
|
2024
Q2 | $3.26M | Buy |
117,441
+2,958
| +3% | +$80.7K | 0.02% | 736 |
|
|
2024
Q1 | $3.15M | Sell |
114,483
-4,657
| -4% | -$126K | 0.02% | 749 |
|
|
2023
Q4 | $3.32M | Sell |
119,140
-3,901
| -3% | -$98.3K | 0.02% | 713 |
|
|
2023
Q3 | $2.92M | Sell |
123,041
-3,865
| -3% | -$92.9K | 0.02% | 724 |
|
|
2023
Q2 | $3M | Sell |
126,906
-644
| -0.5% | -$14.3K | 0.02% | 750 |
|
|
2023
Q1 | $2.83M | Sell |
127,550
-1,918
| -1% | -$45.8K | 0.02% | 769 |
|
|
2022
Q4 | $2.96M | Sell |
129,468
-1,450
| -1% | -$31.3K | 0.02% | 735 |
|
|
2022
Q3 | $2.35M | Sell |
130,918
-1,808
| -1% | -$33.5K | 0.02% | 808 |
|
|
2022
Q2 | $2.4M | Sell |
132,726
-8,364
| -6% | -$179K | 0.02% | 830 |
|
|
2022
Q1 | $3.54M | Buy |
141,090
+39,101
| +38% | +$970K | 0.02% | 731 |
|
|
2021
Q4 | $2.43M | Sell |
101,989
-6,332
| -6% | -$155K | 0.02% | 796 |
|
|
2021
Q3 | $2.55M | Sell |
108,321
-4,349
| -4% | -$102K | 0.02% | 745 |
|
|
2021
Q2 | $2.66M | Sell |
112,670
-11,932
| -10% | -$305K | 0.02% | 739 |
|
|
2021
Q1 | $3.03M | Sell |
124,602
-11,423
| -8% | -$272K | 0.03% | 672 |
|
|
2020
Q4 | $3.02M | Sell |
136,025
-5,085
| -4% | -$104K | 0.03% | 617 |
|
|
2020
Q3 | $2.26M | Sell |
141,110
-9,139
| -6% | -$147K | 0.02% | 664 |
|
|
2020
Q2 | $2.34M | Sell |
150,249
-1,469
| -1% | -$20.2K | 0.03% | 643 |
|
|
2020
Q1 | $1.88M | Hold |
151,718
| – | – | 0.03% | 636 |
|
|
2019
Q4 | $2.75M | Sell |
151,718
-10,425
| -6% | -$177K | 0.03% | 674 |
|
|
2019
Q3 | $2.57M | Sell |
162,143
-4,064
| -2% | -$64.2K | 0.03% | 687 |
|
|
2019
Q2 | $2.77M | Sell |
166,207
-341,279
| -67% | -$5.64M | 0.03% | 659 |
|
|
2019
Q1 | $8.21M | Buy |
507,486
+335,900
| +196% | +$5.69M | 0.02% | 653 |
|
|
2018
Q4 | $2.55M | Sell |
171,586
-354
| -0.2% | -$6.46K | 0.03% | 640 |
|
|
2018
Q3 | $3.65M | Sell |
171,940
-9,695
| -5% | -$203K | 0.04% | 546 |
|
|
2018
Q2 | $3.46M | Buy |
181,635
+3,998
| +2% | +$82.7K | 0.04% | 518 |
|
|
2018
Q1 | $3.85M | Sell |
177,637
-6,694
| -4% | -$158K | 0.05% | 460 |
|
|
2017
Q4 | $4.55M | Buy |
+184,331
| New | +$4.5M | 0.05% | 381 |
|
Other funds holding CNO
MetLife Investment Management's CNO Position: Q2 2026 in Review
MetLife Investment Management increased its CNO Financial Group (CNO) stake by 1.9% in Q2 2026, buying an estimated $85.8K and bringing the position to 98,046 shares worth $5M. The position accounts for 0.02% of the portfolio, ranked #636.
MetLife Investment Management first reported a position in CNO in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.21M in Q1 2019. 383 funds tracked by Wall St. Rank hold CNO as of Q2 2026.
- MetLife Investment Management held 98,046 shares of CNO Financial Group worth $5M as of Q2 2026.
- MetLife Investment Management bought 1,847 CNO Financial Group shares in Q2 2026, an estimated $85.8K.
- CNO Financial Group made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #636 holding.
- MetLife Investment Management first reported a position in CNO Financial Group in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CNO Financial Group position peaked at $8.21M in Q1 2019.
- 383 funds tracked by Wall St. Rank held CNO Financial Group as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.